KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash from Financing Activities (2017 - 2025)

Historic Cash from Financing Activities for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $4.3 million.

  • Guardant Health's Cash from Financing Activities rose 25012.13% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$63.8 million, marking a year-over-year decrease of 16900.02%. This contributed to the annual value of -$996000.0 for FY2024, which is 10020.86% down from last year.
  • As of Q3 2025, Guardant Health's Cash from Financing Activities stood at $4.3 million, which was up 25012.13% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Cash from Financing Activities ranged from a high of $383.9 million in Q2 2023 and a low of -$172.1 million during Q2 2022
  • Its 5-year average for Cash from Financing Activities is $8.4 million, with a median of -$12000.0 in 2022.
  • Within the past 5 years, the most significant YoY rise in Guardant Health's Cash from Financing Activities was 380716.13% (2023), while the steepest drop was 701666.67% (2023).
  • Quarter analysis of 5 years shows Guardant Health's Cash from Financing Activities stood at $3.8 million in 2021, then crashed by 38.68% to $2.3 million in 2022, then surged by 3807.16% to $90.6 million in 2023, then plummeted by 103.24% to -$2.9 million in 2024, then soared by 247.56% to $4.3 million in 2025.
  • Its Cash from Financing Activities stands at $4.3 million for Q3 2025, versus $1.6 million for Q2 2025 and -$66.8 million for Q1 2025.